Xylem Inc
XYL: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$874.00 | Fsyvm | Jsnsdpmm |
Xylem Earnings: Healthy Demand and Supply Chain Improvement Drive Strong Revenue Growth
Narrow-moat-rated Xylem reported strong first-quarter results, featuring a 53% year-over-year increase in adjusted EPS, from $0.47 to $0.72, driven by robust demand across all segments as well as improvement in chip supply. We’ve increased our fair value estimate to $97 from $95, which reflects our slightly more optimistic near-term revenue growth projections as well as time value of money.